BC
PTCT icon

Brookfield Corp’s PTC Therapeutics PTCT Stock Holding History

Brookfield Corp’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-13,795
Closed -$561K – 433
2023
Q2 		$561K Sell
13,795
-90,535
-87% -$4.43M ﹤0.01% 497
2023
Q1 		$5.05M Sell
104,330
-5,429
-5% -$248K 0.02% 289
2022
Q4 		$4.19M Buy
109,759
+41,024
+60% +$1.71M 0.02% 290
2022
Q3 		$3.45M Buy
68,735
+34,150
+99% +$1.67M 0.01% 339
2022
Q2 		$1.39M Sell
34,585
-8,425
-20% -$295K 0.01% 470
2022
Q1 		$1.6M Buy
+43,010
New +$1.66M 0.01% 429

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return